Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US trials for St Jude's dual-chamber ICD (implantable cardioverter defibrillator):

This article was originally published in Clinica

Executive Summary

St Jude Medical has begun US clinical trials for its Photon DR dual-chamber implantable cardioverter defibrillator (ICD). The 46cc device, which combines bradycardia capabilities with tachycardia therapy, has a thickness of 12.7mm and is the thinnest dual-chamber ICD yet, said the St Paul, Minnesota-based company. The Photon has already been implanted in patients in clinical trials in Germany (see Clinica No 891, p 18).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel